Dawson, J. , Merwick, Á., Webb, A., Dennis, M., Ferrari, J. and Fonseca, A. C. (2021) European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA. European Stroke Journal, 6(2), CLXXXVII-CXCI. (doi: 10.1177/23969873211000877)
Text
234543.pdf - Published Version Available under License Creative Commons Attribution. 560kB |
Abstract
Prevention of early recurrent ischaemic stroke remains a priority in people with TIA or ischaemic stroke. A number of trials have recently been completed assessing the efficacy of short-term dual antiplatelet therapy (DAPT) versus single antiplatelet therapy early after minor or moderate stroke or high-risk TIA. We present an Expedited Recommendation for use of dual antiplatelet therapy early after ischaemic stroke and TIA on behalf of the ESO Guideline Board. We make a strong recommendation based on high quality of evidence for use of 21-days of dual antiplatelet therapy with aspirin and clopidogrel in people with a non-cardioembolic minor ischaemic stroke or high-risk TIA in the past 24 hours. We make a weak recommendation based on moderate quality evidence for 30-days of dual antiplatelet therapy with aspirin and ticagrelor in people with non-cardioembolic mild to moderate ischaemic stroke or high-risk TIA in the past 24 hours.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Dawson, Professor Jesse |
Authors: | Dawson, J., Merwick, Á., Webb, A., Dennis, M., Ferrari, J., and Fonseca, A. C. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
Journal Name: | European Stroke Journal |
Publisher: | SAGE Publications |
ISSN: | 2396-9873 |
ISSN (Online): | 2396-9881 |
Published Online: | 11 March 2021 |
Copyright Holders: | Copyright © 2021 European Stroke Organisation |
First Published: | First published in European Stroke Journal 6(2): CLXXXVII-CXCI |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record